Updated WHO definitions for tuberculosis outcomes: Simplified, unified and future-proofed.
作者信息
Stadler J A M
机构信息
Department of Medicine and Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Faculty of Health Sciences, University of Cape Town.
出版信息
Afr J Thorac Crit Care Med. 2022 Jul 15;28(2). doi: 10.7196/AJTCCM.2022.v28i2.224. eCollection 2022.
Abstract
摘要
相似文献
1
Updated WHO definitions for tuberculosis outcomes: Simplified, unified and future-proofed.世界卫生组织结核病转归的更新定义：简化、统一且面向未来。
Afr J Thorac Crit Care Med. 2022 Jul 15;28(2). doi: 10.7196/AJTCCM.2022.v28i2.224. eCollection 2022.
2
Comparison of treatment outcome definitions in drug-resistant tuberculosis patients with high incidence of acquired second-line drug resistance.获得性二线耐药高发生率的耐药结核病患者治疗结局定义的比较
Afr J Thorac Crit Care Med. 2022 Jul 15;28(2). doi: 10.7196/AJTCCM.2022.v28i2.177. eCollection 2022.
3
Clinical Case Definitions for Classification of Intrathoracic Tuberculosis in Children: An Update.儿童胸内结核分类的临床病例定义：更新版
Clin Infect Dis. 2015 Oct 15;61Suppl 3(Suppl 3):S179-87. doi: 10.1093/cid/civ581.
4
Impact of mosquito proofing of night shelters in refugee camps in Kitgum, northern Uganda.乌干达北部基特古姆难民营夜间收容所防蚊措施的影响
Trop Med Int Health. 2007 Mar;12(3):370-6. doi: 10.1111/j.1365-3156.2006.01803.x.
5
A simplified definition of diastolic function in sepsis, compared against standard definitions.与标准定义相比，脓毒症中舒张功能的简化定义。
J Intensive Care. 2019 Feb 20;7:14. doi: 10.1186/s40560-019-0367-3. eCollection 2019.
6
Defining Outcomes of Tuberculosis (Treatment): From the Past to the Future.定义结核病（治疗）结局：从过去到未来。
Respiration. 2021;100(9):843-852. doi: 10.1159/000516392. Epub 2021 May 31.
7
Tuberculosis Diagnosis in HIV-Infected Children: Comparison of the 2012 and 2015 Clinical Case Definitions for Classification of Intrathoracic Tuberculosis Disease.HIV 感染儿童的结核病诊断：2012 年和 2015 年临床病例定义在分类胸内结核病中的比较。
J Pediatric Infect Dis Soc. 2022 Mar 24;11(3):108-114. doi: 10.1093/jpids/piab113.
8
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries.16 个欧洲国家耐多药结核病的临床管理。
Am J Respir Crit Care Med. 2018 Aug 1;198(3):379-386. doi: 10.1164/rccm.201710-2141OC.
9
Consensus Statement on Research Definitions for Drug-Resistant Tuberculosis in Children.儿童耐多药结核病研究定义的共识声明
J Pediatric Infect Dis Soc. 2013 Jun;2(2):100-9. doi: 10.1093/jpids/pit012. Epub 2013 Apr 10.
10
Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel.儿童结核病诊断评估：1. 提出用于分类胸内结核病的临床病例定义。专家小组的共识。
J Infect Dis. 2012 May 15;205 Suppl 2(Suppl 2):S199-208. doi: 10.1093/infdis/jis008. Epub 2012 Mar 22.
引用本文的文献
1
TB programme outcomes in South Fly District, Papua New Guinea, were maintained through COVID-19.巴布亚新几内亚南弗莱地区的结核病防治项目成果在新冠疫情期间得以维持。
Public Health Action. 2024 Dec 1;14(4):139-145. doi: 10.5588/pha.24.0020. eCollection 2024 Dec.
2
Patient and provider costs of the new BPaL regimen for drug-resistant tuberculosis treatment in South Africa: A cost-effectiveness analysis.南非耐多药结核病新 BPaL 方案的患者和提供者成本：成本效益分析。
PLoS One. 2024 Oct 21;19(10):e0309034. doi: 10.1371/journal.pone.0309034. eCollection 2024.
3
Treatment adherence and clinical outcomes amongst in people with drug-susceptible tuberculosis using medication monitor and differentiated care approach compared with standard of care in South Africa: a cluster randomized trial.在南非，与标准治疗相比，采用药物监测和差异化护理方法对药物敏感型肺结核患者进行治疗依从性和临床结局的研究：一项整群随机试验。
EClinicalMedicine. 2024 Jul 27;75:102745. doi: 10.1016/j.eclinm.2024.102745. eCollection 2024 Sep.
4
Cost and cost-effectiveness of BPaL regimen used in drug-resistant TB treatment in the Philippines.菲律宾用于耐药结核病治疗的BPaL方案的成本及成本效益
IJTLD Open. 2024 Jun 1;1(6):242-249. doi: 10.5588/ijtldopen.24.0094. eCollection 2024 Jun.
5
Target product profiles: tests for tuberculosis treatment monitoring and optimization.目标产品概况：用于结核病治疗监测和优化的检测。
Bull World Health Organ. 2023 Nov 1;101(11):730-737. doi: 10.2471/BLT.23.290901. Epub 2023 Oct 4.
本文引用的文献
1
Comparison of treatment outcome definitions in drug-resistant tuberculosis patients with high incidence of acquired second-line drug resistance.获得性二线耐药高发生率的耐药结核病患者治疗结局定义的比较
Afr J Thorac Crit Care Med. 2022 Jul 15;28(2). doi: 10.7196/AJTCCM.2022.v28i2.177. eCollection 2022.
2
Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children.非洲和印度儿童中非重症结核病的更短治疗疗程。
N Engl J Med. 2022 Mar 10;386(10):911-922. doi: 10.1056/NEJMoa2104535.
3
Defining Outcomes of Tuberculosis (Treatment): From the Past to the Future.定义结核病（治疗）结局：从过去到未来。
Respiration. 2021;100(9):843-852. doi: 10.1159/000516392. Epub 2021 May 31.
4
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.利福喷丁四个月方案联合或不联合莫西沙星治疗结核病。
N Engl J Med. 2021 May 6;384(18):1705-1718. doi: 10.1056/NEJMoa2033400.
5
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.耐多药肺结核的治疗。
N Engl J Med. 2020 Mar 5;382(10):893-902. doi: 10.1056/NEJMoa1901814.
6
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.耐药结核病治疗。美国胸科学会/美国疾病控制与预防中心/欧洲呼吸学会/美国感染病学会临床实践指南。
Am J Respir Crit Care Med. 2019 Nov 15;200(10):e93-e142. doi: 10.1164/rccm.201909-1874ST.
7
Outcome definitions for multidrug-resistant tuberculosis treated with shorter treatment regimens.短程治疗方案治疗耐多药结核病的结局定义。
Int J Tuberc Lung Dis. 2019 May 1;23(5):619-624. doi: 10.5588/ijtld.18.0798.
8
Evolution of Programmatic Definitions Used in Tuberculosis Prevention and Care.结核病预防与治疗中使用的规划定义的演变
Clin Infect Dis. 2019 May 2;68(10):1787-1789. doi: 10.1093/cid/ciy990.
9
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries.16 个欧洲国家耐多药结核病的临床管理。
Am J Respir Crit Care Med. 2018 Aug 1;198(3):379-386. doi: 10.1164/rccm.201710-2141OC.
10
Treatment Outcomes in Multidrug-Resistant Tuberculosis.耐多药结核病的治疗结果
N Engl J Med. 2016 Sep 15;375(11):1103-5. doi: 10.1056/NEJMc1603274.
Zotero 插件